223 related articles for article (PubMed ID: 36301099)
1. Diversified Shifts in the Cross Talk between Members of the Gut Microbiota and Development of Coronary Artery Diseases.
Zhang T; Ren H; Du Z; Zou T; Guang X; Zhang Y; Tian Y; Zhu L; Yu J; Yu X; Zhang Z; Dai H
Microbiol Spectr; 2022 Dec; 10(6):e0280422. PubMed ID: 36301099
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota combined with metabolites reveals unique features of acute myocardial infarction patients different from stable coronary artery disease.
Dong C; Yang Y; Wang Y; Hu X; Wang Q; Gao F; Sun S; Liu Q; Li L; Liu J; Tang Y; Zhang S; Wu C; Zhu H
J Adv Res; 2023 Apr; 46():101-112. PubMed ID: 35750287
[TBL] [Abstract][Full Text] [Related]
3. Dysbiosis signatures of gut microbiota in coronary artery disease.
Zhu Q; Gao R; Zhang Y; Pan D; Zhu Y; Zhang X; Yang R; Jiang R; Xu Y; Qin H
Physiol Genomics; 2018 Oct; 50(10):893-903. PubMed ID: 30192713
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein and coronary artery disease.
Auer J; Berent R; Lassnig E; Eber B
Jpn Heart J; 2002 Nov; 43(6):607-19. PubMed ID: 12558125
[TBL] [Abstract][Full Text] [Related]
5. Alterations in gut microbiota and host transcriptome of patients with coronary artery disease.
Chen L; Mou X; Li J; Li M; Ye C; Gao X; Liu X; Ma Y; Xu Y; Zhong Y
BMC Microbiol; 2023 Nov; 23(1):320. PubMed ID: 37924005
[TBL] [Abstract][Full Text] [Related]
6. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
7. The changes of gut microbiota after acute myocardial infarction in rats.
Wu ZX; Li SF; Chen H; Song JX; Gao YF; Zhang F; Cao CF
PLoS One; 2017; 12(7):e0180717. PubMed ID: 28686722
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Metabolomic Characterization of Coronary Artery Diseases.
Fan Y; Li Y; Chen Y; Zhao YJ; Liu LW; Li J; Wang SL; Alolga RN; Yin Y; Wang XM; Zhao DS; Shen JH; Meng FQ; Zhou X; Xu H; He GP; Lai MD; Li P; Zhu W; Qi LW
J Am Coll Cardiol; 2016 Sep; 68(12):1281-93. PubMed ID: 27634119
[TBL] [Abstract][Full Text] [Related]
9. Alterations in the gut mycobiome with coronary artery disease severity.
An K; Jia Y; Xie B; Gao J; Chen Y; Yuan W; Zhong J; Su P; Liu X
EBioMedicine; 2024 May; 103():105137. PubMed ID: 38703606
[TBL] [Abstract][Full Text] [Related]
10. Alterations in the gut microbiome and metabolism with coronary artery disease severity.
Liu H; Chen X; Hu X; Niu H; Tian R; Wang H; Pang H; Jiang L; Qiu B; Chen X; Zhang Y; Ma Y; Tang S; Li H; Feng S; Zhang S; Zhang C
Microbiome; 2019 Apr; 7(1):68. PubMed ID: 31027508
[TBL] [Abstract][Full Text] [Related]
11. Serum neopterin and activity of coronary artery disease.
Auer J; Berent R; Labetanig E; Eber B
Heart Dis; 2001; 3(5):297-301. PubMed ID: 11975809
[TBL] [Abstract][Full Text] [Related]
12. Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease.
Yoshida N; Sasaki K; Sasaki D; Yamashita T; Fukuda H; Hayashi T; Tabata T; Osawa R; Hirata KI; Kondo A
J Atheroscler Thromb; 2019 Aug; 26(8):705-719. PubMed ID: 30587666
[TBL] [Abstract][Full Text] [Related]
13. Characterization of gut microbiota profiles in coronary artery disease patients using data mining analysis of terminal restriction fragment length polymorphism: gut microbiota could be a diagnostic marker of coronary artery disease.
Emoto T; Yamashita T; Kobayashi T; Sasaki N; Hirota Y; Hayashi T; So A; Kasahara K; Yodoi K; Matsumoto T; Mizoguchi T; Ogawa W; Hirata KI
Heart Vessels; 2017 Jan; 32(1):39-46. PubMed ID: 27125213
[TBL] [Abstract][Full Text] [Related]
14. Gut Microbiome-Based Diagnostic Model to Predict Coronary Artery Disease.
Zheng YY; Wu TT; Liu ZQ; Li A; Guo QQ; Ma YY; Zhang ZL; Xun YL; Zhang JC; Wang WR; Kadir P; Wang DY; Ma YT; Zhang JY; Xie X
J Agric Food Chem; 2020 Mar; 68(11):3548-3557. PubMed ID: 32100534
[TBL] [Abstract][Full Text] [Related]
15. Increased serum level of Lp-PLA2 is independently associated with the severity of coronary artery diseases: a cross-sectional study of Chinese population.
Cai A; Li G; Chen J; Li X; Li L; Zhou Y
BMC Cardiovasc Disord; 2015 Feb; 15():14. PubMed ID: 25879827
[TBL] [Abstract][Full Text] [Related]
16. Alterations of Gut Microbiome and Serum Metabolome in Coronary Artery Disease Patients Complicated With Non-alcoholic Fatty Liver Disease Are Associated With Adverse Cardiovascular Outcomes.
Hu X; Zhou R; Li H; Zhao X; Sun Y; Fan Y; Zhang S
Front Cardiovasc Med; 2021; 8():805812. PubMed ID: 35047580
[No Abstract] [Full Text] [Related]
17. MiR-423 is differentially expressed in patients with stable and unstable coronary artery disease: A pilot study.
Rizzacasa B; Morini E; Mango R; Vancheri C; Budassi S; Massaro G; Maletta S; Macrini M; D'Annibale S; Romeo F; Novelli G; Amati F
PLoS One; 2019; 14(5):e0216363. PubMed ID: 31059534
[TBL] [Abstract][Full Text] [Related]
18. [Gut microbiota and its metabolite trimethylamine-N-oxide (TMAO): a novel regulator in coronary artery disease].
Li Y; Cui M; Sun J; Wei Q; Liu M; Zhang J; Qi H; Zhao L; Fang H; Chen Z; Lü S
Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3745-3756. PubMed ID: 34841781
[TBL] [Abstract][Full Text] [Related]
19. Plasma vaspin concentrations are decreased in acute coronary syndrome, but unchanged in patients without coronary lesions.
Zhang B; Peng W; Li H; Lu Y; Zhuang J; Wang K; Su Y; Xu Y
Clin Biochem; 2013 Oct; 46(15):1520-5. PubMed ID: 23850850
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota metabolic characteristics in coronary artery disease patients with hyperhomocysteine.
Tian R; Liu HH; Feng SQ; Wang YF; Wang YY; Chen YX; Wang H; Zhang SY
J Microbiol; 2022 Apr; 60(4):419-428. PubMed ID: 35246806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
